Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Anaemia megaloblastic
ADR ID BADD_A00185
ADR Hierarchy
01      Blood and lymphatic system disorders
01.03      Anaemias nonhaemolytic and marrow depression
01.03.02      Anaemias NEC
01.03.02.003      Anaemia megaloblastic
14      Metabolism and nutrition disorders
14.12      Vitamin related disorders
14.12.01      Vitamin deficiencies NEC
14.12.01.003      Anaemia megaloblastic
Description A disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS. [MeSH]
MedDRA Code 10002065
MeSH ID D000749
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Anaemia megaloblastic | Anemia megaloblastic | Megaloblastic anaemia NOS | Megaloblastic anemia | Megaloblastosis | Other specified megaloblastic anaemias, not elsewhere classified | Other specified megaloblastic anemias not elsewhere classified | Other specified megaloblastic anemias, not elsewhere classified | Megaloblastic anaemia | Anemia, Megaloblastic | Anemias, Megaloblastic | Megaloblastic Anemia | Megaloblastic Anemias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02091Sulfamethoxazole--
BADD_D02093Sulfasalazine--
BADD_D02100Sunitinib0.000112%
BADD_D02150Temozolomide0.000112%
BADD_D02192Thalidomide--
BADD_D02275Triamterene--
BADD_D02276Triamterene hydrochlorothiazide--
BADD_D02290Trimethoprim--
BADD_D02291Trimethoprim hydrochloride--
BADD_D02331Valsartan0.000079%
BADD_D02369Voriconazole--
The 2th Page    First    Pre   2    Total 2 Pages